MAP3K13
Reactivity: Human, Mouse
WB, IF (cc), IF (p)
Host: Rabbit
Polyclonal
Cy3
Application Notes
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,ELISA 1:20000,IF 1:50-200
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Expiry Date
12 months
Target
MAP3K13
(Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
Alternative Name
LZK
Background
MAP3K13, LZK, Mitogen-activated protein kinase kinase kinase 13, Leucine zipper-bearing kinase, Mixed lineage kinase, MLKMitogen-activated protein kinase kinase kinase 13 encoded by MAP3K13 is a member of serine/threonine protein kinase family. Mitogen-activated protein kinase kinase kinase 13 contains a dual leucine-zipper motif, and has been shown to form dimers/oligomers through its leucine-zipper motif. Mitogen-activated protein kinase kinase kinase 13 can phosphorylate and activate MAPK8/JNK, MAP2K7/MKK7, which suggests a role in the JNK signaling pathway.